Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer...Definitions Matter
This podcast reviews the International Bladder Cancer Group\u2019s recommendations regarding definitions and endpoints for the development of non-muscle-invasive bladder cancer clinical trials.